You searched for "burn"
Illuminating task lighting
Good lighting is always important but especially for patients who are visually impaired. Janet Pooley provides an overview. We tend to discuss lighting with patients when their vision is reduced, and where we are considering higher reading adds or low...New support pathway for children with sight loss launches to address vital need for consistency of care
A new eye care support pathway to help children and young people with a vision impairment get the support they need, has been launched today by partners from across the sight loss sector. This sets out the care and services...Low Vision Questionnaire
Participation in this survey is greatly appreciated and will help eyecare practitioners to provide the support patients with vision loss deserve.Take part in the 'Whole Eye OCT Experience' at 100% Optical 2024
The Whole Eye OCT Experience is being delivered in association with The Partially Sighted Society: a charity that helps anybody living with vision loss make the best use of their remaining vision.Applications closing soon for leadership and management training and qualifications
Optical professionals who want to boost their career in management are encouraged to apply now for the leadership and management courses from the Association of British Dispensing Opticians (ABDO). Study is carried out 100% online and the closing date for applications for training leading to these qualifications is Thursday 4 April 2024.CHEC expands transformative MIGS service
CHEC, a community healthcare provider delivering specialist ophthalmology services on behalf of the NHS, has announced the expansion of its minimally invasive glaucoma surgery (MIGS) service. MIGS is an innovative approach combining glaucoma treatment with cataract surgery, utilising advanced techniques...
Medical treatment of orbital lymphatic malformations
This is a literature review of the use of Sirolimus, to treat orbital lymphatic malformations. Sirolimus is an immunosuppressant used in renal transplants, and acts by inhibiting mammalian target of rapamycin (mTOR), which in turn inhibits activation of T and...
